P988: MUTANT CALRETICULIN AND JAK2V617F DRIVER MUTATIONS INDUCE DISTINCT MITOTIC DEFECTS IN MYELOPROLIFERATIVE NEOPLASMS

Lignende værker

• Calreticulin and JAK2V617F driver mutations induce distinct mitotic defects in myeloproliferative neoplasms
  af: Kristin Holl, et al.
  Udgivet: (2024-02-01)
• Mutant Calreticulin in the Myeloproliferative Neoplasms
  af: Daniel Prins, et al.
  Udgivet: (2020-02-01)
• The telomerase inhibitor imetelstat differentially targets JAK2V617F versus CALR mutant myeloproliferative neoplasm cells and inhibits JAK-STAT signaling
  af: Kathrin Olschok, et al.
  Udgivet: (2023-10-01)
• Secreted mutant calreticulins as rogue cytokines in myeloproliferative neoplasms
  af: Pecquet, C, et al.
  Udgivet: (2022)
• Inflammation and anti-inflammatory approaches in myeloproliferative neoplasm
  af: Steffen Koschmieder, et al.
  Udgivet: (2018-06-01)